## OMCL: Omnicell, Inc. - XLV: Healthcare

### Executive Summary

No thesis match: MRS_10 1.9% below STRENGTH zone (3.0-6.0%); PEG 2.28 fails VALUE criteria (<1.0); RSI 71 overbought. Stock is in no-man's land without clear edge. Caution: overbought RSI (71).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($44.17)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 1
- **Sentiment:** Bearish (Bullish: 0, Bearish: 0)

**1. Voya Investment Management LLC Cuts Stock Position in Omnicell, Inc. $OMCL**
- Source: MarketBeat | 20260104T130941 | Somewhat-Bearish | Relevance: 100%
- Voya Investment Management LLC significantly reduced its stake in Omnicell, Inc. (NASDAQ:OMCL) during the third quarter, selling 35,694,801 shares and now holding 14,167 shares valued at $431,000. Despite this, institutional ownership remains high at 97.70%, with several other funds adjusting their positions. Analyst ratings for Omnicell are mixed, with a consensus "Hold" rating and a $43.00 target price.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2026-01-05 | Wells Fargo | $52 | $43 | +21% |
| 2025-12-09 | B of A Securiti | $46 | $36 | +28% |
| 2025-12-09 | Benchmark | $50 | $45 | +11% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2026-01-05 | Wells Fargo | main | Overweight |
| 2025-12-09 | B of A Securiti | main | Neutral |
| 2025-12-09 | Benchmark | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 10 ($2.25M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 58.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 3 / 7 |

**Top Holders:**
- Blackrock Inc.: 17.1% (-2.3%)
- Vanguard Group Inc: 12.5% (-0.4%)
- Dimensional Fund Adv: 5.3% (+9.1%)
- Cadian Capital Manag: 4.7% (+25.9%)
- State Street Corpora: 4.6% (-2.0%)

### Key Risks

1. Elevated short interest (8.9%): bears positioning against stock.
2. Overbought RSI (71) with bearish MACD signals exhaustion.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Analyst target momentum: 3 raises (avg +20%) could attract flows.
- Momentum building: MRS_10 improving +2.3% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 2.28 elevated, pricing in significant growth expectations. Forward P/E 25.5x stretched relative to 8% growth. Analyst sentiment positive (3 raises, avg +20%). Insider selling cluster ($2.2M in 90 days), potential headwind. Institutional flow bullish (3 buying vs 7 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $2.2B |
| Beta | 0.78 |
| 52W Range | $22.66 - $47.69 |
| Short Interest | 8.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.28 |
| Forward P/E | 25.5 |
| Current P/E | 27.5 |
| YoY Growth | 7.8% |
| EPS Direction | RISING |

### Technicals

MRS_10 strengthening from -0.4% to 1.9% (+2.3% in 5 days), confirming momentum buildup. Below STRENGTH zone by 1.1pp (needs >3.0% for momentum thesis). MRS_5 at 1.4% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). RSI overbought at 71, risk of mean reversion. OFD pattern: +SLL (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.92% (CS: 59) | Neutral |
| RSI_14 | 70.6 | Overbought |
| MACD Histogram | -0.25 | Bearish |
| vs SMA20 | 1.040x | Above |
| vs SMA50 | 1.198x | Above |
| vs SMA200 | 1.438x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $47.07
- **Stop Loss:** $44.17 (6.2% risk)
- **Target:** $49.97 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 455
- **Position Value:** $21,416.85
- **Portfolio %:** 21.42%
- **Risk Dollars:** $1,320.00
- **Risk Per Trade:** 1.32%
- **Modifiers:** L1 110% | L2 120% | Combined 1.32x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | RISK_ON (MEDIUM) | 1.10x |
| L2 Sector | TREND (Zone A) | 1.20x |

*RISK_ON regime with strong participation and low volatility. VIX at 14.75 (6th percentile) with breadth at 63.5% signals healthy risk appetite. Fed dovish expectations and AI/semiconductor momentum are primary drivers, though elevated put/call ratio suggests smart money hedging. Focus on quality growth with awareness of potential complacency.*

### Earnings

**Next:** 2026-02-05 (Est: $0.49)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.36 | $0.51 | +40.7% |
| 2025Q2 | $0.27 | $0.45 | +66.7% |
| 2025Q1 | $0.20 | $0.26 | +27.1% |
| 2024Q4 | $0.58 | $0.60 | +2.8% |

---
*RULE-based L3 | 2026-01-07 08:25 | MRS_10*